Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
1823
JPY million (year-on-year decrease in operating profit)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFull year of the fiscal year ending March 2026 (FY2025)9 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥96,300 million+0.8%
Operating profit¥6,900 million-20.9%
Ordinary income¥7,704 million-18.2%
Net income¥7,035 million-25.1%
Operating profit margin7.2% in fiscal 2025, compared with 9.1% in the previous fiscal year (down 1.9 percentage points year on year)
Results for the three months of the current quarter
Standalone fourth quarter of FY2025
Net Sales
¥23,796 million
Operating profit
¥1,184 million
Ordinary income
¥1,301 million
Profit attributable to owners of parent for the quarter
¥1,086 million
Full-year earnings forecast
Fiscal 2026
Net Sales
¥100,000 million
Operating profit
¥7,100 million
Ordinary income
¥7,600 million
Profit attributable to owners of the parent
¥7,500 million
ROE
9 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
A challenging first year relative to the targets of Medium-Term Plan 2027Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Revenue impact of foreign exchange movements¥357 million
- Operating profit impact of foreign exchange movements¥-33 million
- Total labor and personnel expenses¥931 million
- Energy costs¥-126 million
- Advertising expenses¥-194 million
- Logistics Costs¥-75 million
- Impact of asbestos¥-872 million
New initiatives
- Price revisions in the domestic food business, stronger proposals for new products, and increased sales of ingredients for functional foods
- Pursue cost reductions and expand specialty products in the overseas business, with the aim of returning to profitability in fiscal 2027
Key KPIsA metric the company considers important as a management benchmark.
- ROE8.7 %Year on year against the same period last year-3.4%Year-on-year comparison unitPoints
- Equity ratio71.6 %Year on year against the same period last year+1.5%Year-on-year comparison unitPoints
Segment results
- Domestic Food BusinessNet Sales¥66,360 million (YoY +2.4%)Operating profit¥6,417 million (YoY -3.6%)
- Domestic Chemical Products and Other BusinessesNet Sales¥8,686 million (YoY +9.1%)Operating profit¥857 million (YoY -4.2%)
- Overseas BusinessNet Sales¥22,893 million (YoY -5.4%)Operating profit¥-436 million
Medium-term management plan targets
A challenging first year relative to the targets of Medium-Term Plan 2027. Specific target figures: not disclosedFinancial targets
ROE
Actual results8.7 %
FY2026 forecast9 %
Equity ratio
Actual results71.6 %
Annual Dividend
FY2025
Interim¥55 per share
End of period¥55 per share
Annual¥110 per share
FY2026 forecast
Interim¥55 per share
End of period¥55 per share
Annual¥110 per share
Payout ratio
FY202546.2 %
FY2026 forecast42.8 %
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Full year of the fiscal year ending March 2026 (FY2025) |
| Net Sales | ¥96,300 million (YoY +0.8%) |
| Operating profit | ¥6,900 million (YoY -20.9%) |
| Ordinary income | ¥7,704 million (YoY -18.2%) |
| Net income | ¥7,035 million (YoY -25.1%) |
| Operating profit margin | 7.2% in fiscal 2025, compared with 9.1% in the previous fiscal year (down 1.9 percentage points year on year) |
| Results for the three months of the current quarter | Subject Standalone fourth quarter of FY2025 / Net Sales ¥23,796 million / Operating profit ¥1,184 million / Ordinary income ¥1,301 million / Profit attributable to owners of parent for the quarter ¥1,086 million |
| Full-year earnings forecast | Subject Fiscal 2026 / Net Sales ¥100,000 million / Operating profit ¥7,100 million / Ordinary income ¥7,600 million / Profit attributable to owners of the parent ¥7,500 million / ROE 9 % |
| Self-assessment against the plan | A challenging first year relative to the targets of Medium-Term Plan 2027 |
| Segment results | Segment Domestic Food Business / Net Sales ¥66,360 million (YoY +2.4%) / Operating profit ¥6,417 million (YoY -3.6%), Segment Domestic Chemical Products and Other Businesses / Net Sales ¥8,686 million (YoY +9.1%) / Operating profit ¥857 million (YoY -4.2%), Segment Overseas Business / Net Sales ¥22,893 million (YoY -5.4%) / Operating profit ¥-436 million |
| Breakdown of Factors Affecting the Change | Factors Revenue impact of foreign exchange movements / Amount ¥357 million, Factors Operating profit impact of foreign exchange movements / Amount ¥-33 million, Factors Total labor and personnel expenses / Amount ¥931 million, Factors Energy costs / Amount ¥-126 million, Factors Advertising expenses / Amount ¥-194 million, Factors Logistics Costs / Amount ¥-75 million, Factors Impact of asbestos / Amount ¥-872 million |
| Key KPIs | Indicator name ROE / Value 8.7 % / Year on year against the same period last year -3.4 % / Year-on-year comparison unit Points, Indicator name Equity ratio / Value 71.6 % / Year on year against the same period last year 1.5 % / Year-on-year comparison unit Points |
| Medium-term management plan targets | A challenging first year relative to the targets of Medium-Term Plan 2027. Specific target figures: not disclosed |
| Financial targets | ROE Actual results 8.7 % / FY2026 forecast 9 % / Equity ratio Actual results 71.6 % |
| Annual Dividend | FY2025 Interim ¥55 per share / End of period ¥55 per share / Annual ¥110 per share / FY2026 forecast Interim ¥55 per share / End of period ¥55 per share / Annual ¥110 per share |
| Payout ratio | FY2025 46.2 % / FY2026 forecast 42.8 % |
| New initiatives | Price revisions in the domestic food business, stronger proposals for new products, and increased sales of ingredients for functional foods, Pursue cost reductions and expand specialty products in the overseas business, with the aim of returning to profitability in fiscal 2027 |
Items this document does not state (13)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the domestic business, higher costs, including labor and personnel expenses, were offset through price revisions and lower advertising expenses. However, operating income declined by ¥872 million following a change in the estimate for asset retirement obligations related to asbestos removal costs. In the overseas business, factors behind the operating loss included weak consumption in China, lower sales volumes amid intensifying price competition in Europe and Southeast Asia, lower gross profit due to declining revenue, and higher personnel expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.